Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin55.4%+38.7pp33.3%+6.8pp36.3%+20.1pp23.8%+4.8pp16.7%+266pp
Net margin28.3%+38.4pp8.1%+7.9pp8.4%+9.1pp-2.6%-4.9pp-10.2%+244pp
EBITDA margin55.9%+38.8pp33.9%+7.1pp36.8%+20.2pp24.3%+5.0pp17.1%+266pp
Returns
Return on assets26.8%+35.3pp6.4%+6.2pp7.3%+7.8pp-2.1%-4.0pp-8.4%+124pp
Efficiency
Asset turnover0.9×+0.1×0.8×-0.1×0.9×0.0×0.8×0.0×0.8×+0.3×
Liquidity
Current ratio1.4×-1.9×1.1×-3.6×1.1×-2.5×0.8×-3.1×3.3×+2.5×
Quick ratio1.4×-1.9×1.1×-3.6×1.1×-2.5×0.8×-3.1×3.3×+2.5×
Cash ratio0.9×-1.3×0.9×-1.4×0.6×-1.2×0.4×-1.9×2.3×+1.8×
Leverage
Debt-to-assets0.5×+0.4×0.5×+0.5×0.5×+0.5×0.6×+0.6×-0.4×
Net debt / EBITDA-0×+1.7×-0×+0.7×0.6×+1.7×1.6×+2.8×-1.7×
Interest coverage5.9×+4.4×+0.2×3.6×+1.8×2.1×-0.2×1.6×+39.3×
Per Share
Book value per share-$1.30+37.2%-$1.61+14.7%-$1.49+23.5%-$1.74+13.9%-$2.08+1.0%
Valuation
Market capitalization$632.12M+457%$548.23M-22.7%$212.79M-67.5%$117.45M-88.6%$235.24M-82.7%
Enterprise value$624M+3,024%$545.57M-14.2%$285.62M-51.0%$238.27M-74.6%$141.68M-90.3%
Price / earnings6.2×22.8×-783×7.5×
Price / sales1.8×+1.4×1.9×-0.2×0.6×-1.1×0.4×-2.2×0.7×-2.5×
EV / EBITDA3.1×+2.7×5.4×-1.3×2.3×-7.0×3.2×-9.0×2.6×
EV / sales1.7×+1.7×1.8×0.0×0.8×-0.7×0.8×-1.6×0.4×-3.1×
Earnings yield16.2%+44.7pp4.4%+4.3pp13.4%+13.8pp-6.7%-7.6pp-13.7%+63.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ironwood Pharmaceuticals's profit margins?
Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 55.4% operating margin, with a 28.3% net margin.
Where do Ironwood Pharmaceuticals's ratios come from?
Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.